|
71 |
Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance
Enthalten in Nature Communications Bd. 15, 12.1.2024, Nr. 1, date:12.2024: 1-13
|
|
|
|
72 |
Futures literacy in collaborative foresight networks: advancing sustainable shipbuilding
Enthalten in European Journal of Futures Research Bd. 11, 26.10.2023, Nr. 1, date:12.2023: 1-19
|
|
|
|
73 |
Gene transcript fusions are associated with clinical outcomes and molecular groups of meningiomas
Enthalten in Acta neuropathologica Bd. 147, 20.3.2024, Nr. 1, date:6.2024: 1-5
|
|
|
|
74 |
Glioblastoma remodelling of human neural circuits decreases survival
Enthalten in Nature Bd. 617, 3.5.2023, Nr. 7961, date:5.2023: 599-607
|
|
|
|
75 |
Glioma-neuronal circuit remodeling induces regional immunosuppression
Enthalten in Nature Communications Bd. 16, 22.5.2025, Nr. 1, date:12.2025: 1-19
|
|
|
|
76 |
High-Grade Progression, Sarcomatous Transformation, and/or Metastasis of Pituitary Neuroendocrine Neoplasms (PitNENs): The UCSF Experience
Enthalten in Endocrine pathology Bd. 35, 10.10.2024, Nr. 4, date:12.2024: 338-348
|
|
|
|
77 |
In vivo perturb-seq of cancer and microenvironment cells dissects oncologic drivers and radiotherapy responses in glioblastoma
Enthalten in Genome biology Bd. 25, 7.10.2024, Nr. 1, date:12.2024: 1-32
|
|
|
|
78 |
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
Enthalten in Acta neuropathologica Bd. 146, 24.4.2023, Nr. 1, date:7.2023: 145-162
|
|
|
|
79 |
Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas
Enthalten in Acta neuropathologica Bd. 145, 1.2.2023, Nr. 4, date:4.2023: 497-500
|
|
|
|
80 |
Massive ganglioneuroma of the parapharyngeal space in a pediatric patient: a case report
Enthalten in The Egyptian journal of otolaryngology Bd. 38, 20.8.2022, Nr. 1, date:12.2022: 1-5
|
|
Administration
